<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00599599</url>
  </required_header>
  <id_info>
    <org_study_id>R34MH071201-01A1</org_study_id>
    <secondary_id>NIMH, 1 R34 MH071201-01A1</secondary_id>
    <nct_id>NCT00599599</nct_id>
  </id_info>
  <brief_title>Stress-Reducing Interventions in HIV+ Patients: Pilot</brief_title>
  <acronym>PEACH</acronym>
  <official_title>Pilot Intervention for PTSD, Nonadherence, and HIV Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kent State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Summa Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kent State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this project is to examine the efficacy of prolonged exposure (PE) therapy
      at reducing HIV-related PTSD symptoms, increasing adherence to antiretroviral medication
      regimens, and increasing health-related quality of life (QOL) in HIV+ patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HIV+ patients will be randomized to receive either PE therapy (up to 18 possible sessions) or
      weekly symptom monitoring (described below) and will complete measures of PTSD, adherence,
      and QOL pre- and post-intervention and at 3- and 6-month follow-up assessments. Secondary
      analyses will examine the impact of the intervention on disorders commonly comorbid with PTSD
      (i.e., anxiety, mood, and substance abuse/dependence disorders).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2005</start_date>
  <completion_date type="Anticipated">February 2010</completion_date>
  <primary_completion_date type="Anticipated">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PTSD symptoms</measure>
    <time_frame>pre- &amp; post-intervention, 3-month post, &amp; 6-month post</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to HIV medications</measure>
    <time_frame>pre- &amp; post-intervention, 3-month post, &amp; 6-month post</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>pre- &amp; post-intervention, 3-month post, &amp; 6-month post</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Stress Disorders, Post-Traumatic</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prolonged Exposure Therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Weekly monitoring/Waitlist Control Group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prolonged Exposure Therapy</intervention_name>
    <description>Participants will meet with a therapist twice a week for 5 weeks to complete the therapy. If the therapist and participant feel more sessions are needed, an additional 8 sessions will be provided.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be HIV+

          -  Must meet PTSD diagnostic criteria

          -  Must be taking HIV medications

          -  Must be able to read and write in English

        Exclusion Criteria:

          -  Current or previous diagnosis of schizophrenia, any current diagnosis with psychotic
             features, or current suicidal ideation

          -  Being in a current abusive relationship or ongoing intimate relationship with one's
             assailant

          -  Mental retardation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas L Delahanty, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kent State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Violet's Cupboard</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44310</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AIDS Taskforce of Greater Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2008</study_first_submitted>
  <study_first_submitted_qc>January 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2008</study_first_posted>
  <last_update_submitted>March 4, 2009</last_update_submitted>
  <last_update_submitted_qc>March 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2009</last_update_posted>
  <responsible_party>
    <name_title>Douglas L. Delahanty, Professor</name_title>
    <organization>Kent State University</organization>
  </responsible_party>
  <keyword>Prolonged Exposure Therapy</keyword>
  <keyword>Adherence to HIV Medications</keyword>
  <keyword>Complementary Therapies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 9, 2014</submitted>
    <returned>May 8, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

